Colossal Biosciences Raises $120 Million to Advance Dodo De-Extinction and Avian Research

With backing from Peter Jackson and top investors, Colossal secures $120M to accelerate its mission to resurrect the dodo and expand avian conservation science.

BY Emily Forgash

Colossal Biosciences raised $120M in new funding—bringing total backing to $555M and a ~$10.3B valuation—to accelerate avian R&D in Texas and its dodo de-extinction program. The round follows a major lab milestone: long-term culture of pigeon primordial germ cells, a pivotal step toward creating dodo-like offspring and new tools for endangered bird conservation. In parallel, the company’s de-extinction pipeline spans mammoth, thylacine, and moa research. Earlier this year, Colossal introduced three pups in its Colossal dire wolf project—an emblem of how breakthroughs can translate to modern conservation. Together, the funding and science signal faster timelines and broader applications for restoring lost traits while protecting at-risk species.

Full feature on Bloomberg.